Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABIRATERONE for Bladder cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where ABIRATERONE was used for Bladder cancer.

Most Reported Side Effects for ABIRATERONE

Side Effect Reports % Deaths Hosp.
Death 5,623 16.3% 5,571 308
Fatigue 1,928 5.6% 77 299
Drug ineffective 1,732 5.0% 106 145
Therapy cessation 1,602 4.6% 17 123
Prostatic specific antigen increased 1,581 4.6% 96 182
Disease progression 1,098 3.2% 122 76
Hospitalisation 1,034 3.0% 99 983
Hot flush 989 2.9% 14 86
Asthenia 891 2.6% 79 333
Off label use 859 2.5% 100 231
Fall 804 2.3% 67 476
Nausea 735 2.1% 62 196
Diarrhoea 731 2.1% 57 204
Hypertension 687 2.0% 43 200
Prostate cancer 661 1.9% 267 163

Other Indications for ABIRATERONE

Product used for unknown indication (12,433) Prostate cancer (12,209) Prostate cancer metastatic (3,535) Hormone-refractory prostate cancer (1,378) Neoplasm malignant (266) Hormone-dependent prostate cancer (236) Metastases to bone (147) Prostate cancer stage iv (94) Bone cancer (67) Neoplasm prostate (50)

Other Drugs Used for Bladder cancer

BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279) PEMBROLIZUMAB (869) GEMCITABINE (841) CISPLATIN (780) ENFORTUMAB VEDOTIN-EJFV (530) NIVOLUMAB (512) ATEZOLIZUMAB (487) CARBOPLATIN (332) BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326) GEMCITABINE\GEMCITABINE (240)

Related Pages

ABIRATERONE Full Profile All Bladder cancer Drugs ABIRATERONE Demographics ABIRATERONE Timeline